<--- Back to Details
First PageDocument Content
Cancer organizations / Immunosuppressants / International Myeloma Foundation / International Myeloma Working Group / Norwalk /  Connecticut / Multiple myeloma / Myeloma Canada / Lenalidomide / Bortezomib / Medicine / Oncology / Cancer research
Date: 2013-10-31 18:22:19
Cancer organizations
Immunosuppressants
International Myeloma Foundation
International Myeloma Working Group
Norwalk
Connecticut
Multiple myeloma
Myeloma Canada
Lenalidomide
Bortezomib
Medicine
Oncology
Cancer research

Myeloma Today FALL[removed]Volume 9 Number 8

Add to Reading List

Source URL: myeloma.org

Download Document from Source Website

File Size: 4,60 MB

Share Document on Facebook

Similar Documents

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REVLIMID® safely and effectively. See full prescribing information for REVLIMID. REVLIMID [lenalidomide] capsules,

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REVLIMID® safely and effectively. See full prescribing information for REVLIMID. REVLIMID [lenalidomide] capsules,

DocID: 1tonS - View Document

Revlimid, INN-lenalidomide

Revlimid, INN-lenalidomide

DocID: 1szTz - View Document

Pipette, Seite 11–13 Monoklonale Gammopathien: Neue IMWG-Kriterien und Labortests für die Diagnose, Prognose und Verlaufskontrolle des Multiplen Myeloms Luca Bernasconi, Esther Mundwiler Referenzen 1.

Pipette, Seite 11–13 Monoklonale Gammopathien: Neue IMWG-Kriterien und Labortests für die Diagnose, Prognose und Verlaufskontrolle des Multiplen Myeloms Luca Bernasconi, Esther Mundwiler Referenzen 1.

DocID: 1rfhH - View Document

12-AUG:10 MMYEL ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

12-AUG:10 MMYEL ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

DocID: 1qMvA - View Document

PUBLICATION DU GINECO  Année 2014 Selle F, Sevin E, Ray-Coquard I, Mari V, Berton-Rigaud D, Favier L, Fabbro M, Lesoin A,.Lortholary A, PujadeLauraine E. A phase II study of lenalidomide in platinum-sensitive recurrent

PUBLICATION DU GINECO Année 2014 Selle F, Sevin E, Ray-Coquard I, Mari V, Berton-Rigaud D, Favier L, Fabbro M, Lesoin A,.Lortholary A, PujadeLauraine E. A phase II study of lenalidomide in platinum-sensitive recurrent

DocID: 1qvQ0 - View Document